Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
09/2008
09/25/2008US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors
09/25/2008US20080234269 N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands
09/25/2008US20080234221 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents
09/25/2008US20080233606 Use of raman spectroscopy in enzyme activity assays
09/25/2008CA2681466A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
09/24/2008EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/24/2008CN101273038A Macrocylic inhibitors of hepatitis C virus
09/24/2008CN101273016A Antibacterial quinoline derivatives
09/24/2008CN101270085A Bis(8-quinoline diazo amido)-biphenyl, preparation method and application thereof
09/24/2008CN101270084A Novel pitavastatin nitryl ester derivant
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/18/2008WO2008111632A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative
09/18/2008WO2008110355A1 Quinoline derivatives as fungicides
09/18/2008US20080227979 Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these
09/18/2008US20080227812 Spiro Substituted Compounds As Angiogenesis Inhibitors
09/18/2008US20080227811 Benzyl 1-((4-(1H-indol-5-ylamino)-6-methoxyquinolin-7-yloxy)methyl)cyclopropylcarbamate; cancers associated with protein tyrosine kinases
09/18/2008US20080227810 6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
09/18/2008US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
09/18/2008US20080226622 Hypoxia inducible factor (Hif); for modulating mRNA translation within cells; prevents excessive vascularization
09/18/2008CA2679714A1 Quinoline derivatives as fungicides
09/17/2008EP1970371A1 Pyrido(3,2-h)chinazolins and/or 5,6-Dihydro derivatives thereof, method for their manufacture and endowed organic semiconductor material containing them
09/17/2008EP1968968A1 Compositions and methods for modulating gated ion channels
09/17/2008EP1968944A1 Alkylsulphonamide quinolines
09/17/2008EP1968943A1 An improved process for the preparation of montelukast and its pharmaceutically acceptable salts
09/17/2008EP1968942A1 An improved process for the manufacture of montelukast sodium
09/17/2008EP1968938A1 Substituted propiolic acid amides and their use for producing drugs
09/17/2008EP1272827B1 Analyte detection
09/17/2008CN101268072A DNA-PK inhibitors
09/17/2008CN101268053A Alkylnitrile quinolines, as NK-3 receptor ligands
09/17/2008CN101268052A N-oxo-heterocycle and N-oxo-alkyl quinoline-4-carboxamides as NK-3 receptor ligands
09/17/2008CN100418950C Process for the manufacture of quinoline derivatives
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425564 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same
09/12/2008WO2008109829A1 Cyclopamine lactam analogs and methods of use thereof
09/12/2008WO2008109007A1 Bridged phenanthridines
09/12/2008WO2008107478A1 Quinolinone derivatives as parp and tank inhibitors
09/12/2008CA2679845A1 Cyclopamine lactam analogs and methods of use thereof
09/12/2008CA2678248A1 Quinolinone derivatives as parp and tank inhibitors
09/11/2008US20080221177 for controlling phytopathogenic harmful fungi
09/11/2008US20080221161 treatment or prevention of metabolic, cardiovascular, and inflammatory diseases; 1-(7-methoxy-2-(thiophen-3-yl)quinolin-3-yl)-N-(4-(trifluoromethyl)benzyl)methanamine
09/11/2008US20080221160 Sulfonylated heterocycles useful for modulation of the progesterone receptor
09/11/2008US20080221159 Inhibitors of human immunodeficiency virus replication
09/11/2008US20080221157 (2S)-2-{[(5-Methoxy-2-methyl-1H-indol-3-yl)acetyl]amino}-8-oxo-N-[2-(2-phenyl-1H-indol-3-yl)ethyl]nonanamide; treating neurodegenerative diseases, schizophrenia and stroke
09/11/2008US20080221078 Use of a CB1 Antagonist for Treating Side Effects and Negative Symptoms of Schizophrenia
09/10/2008CN101263119A Novel 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity
09/10/2008CN101263116A Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase
09/10/2008CN101260079A Method for preparing 7,8-dihydroquinolin-2,5(1H,6H)-diones derivatives
09/10/2008CN101260078A Method for preparing 7,8-dihydroquinolin-5(6H)-ones derivatives
09/10/2008CN101260077A Quinolin-2-ones derivative, pharmaceutical composition and use thereof
09/09/2008US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
09/09/2008US7423153 Crystalline forms of gatifloxacin
09/09/2008US7423035 e.g. 5-hydroxy-8-{1-hydroxy-2-[1-(4-methoxy-benzyl)-cyclopropylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity
09/09/2008CA2460865C Quinoline derivatives as neuropeptide y antagonists
09/04/2008WO2008105515A1 Novel hydroxamic acid derivative
09/04/2008WO2008104781A1 Process for preparing isomers of carmoterol
09/04/2008US20080216184 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
09/04/2008US20080214823 Removing solvent from a solution comprising montelukast sodium using agitated thin film drying; storage stability; pure; leukotriene receptor antagonist
09/04/2008US20080214822 Process For the Preparation of a Leukotriene Antagonist
09/04/2008US20080214608 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics
09/04/2008US20080214607 Heteroaromatic quinoline compounds
09/04/2008US20080214605 to potentiate the effects of the other CNS agents; probes for the localization of cell surface receptors;3-(methylthio)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide; depression, anxiety, schizophrenia, cognitive disorders, obesity, irritable bowel syndrome, emesis, pre-eclampsia, etc.
09/04/2008US20080214394 N-(4-Pyridyl)Methylsulfonamides For Combating Arthropodal Pests
09/04/2008US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A
09/04/2008CA2679059A1 Process for preparing isomers of carmoterol
09/03/2008EP1964925A1 Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines
09/03/2008EP1964837A1 Anti-tumor agent for multiple myeloma
09/03/2008EP1963272A1 Hydroxyquinoline derivatives
09/03/2008EP1963271A1 Quinolone m1 receptor positive allosteric modulators
09/03/2008EP1962849A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
09/03/2008EP1879581B1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
09/03/2008EP1730112B1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
09/03/2008EP1262477B1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
09/03/2008CN101258129A Quinoline derivatives and use as antitumor agents
09/03/2008CN101255434A Vaccines
09/03/2008CN100415737C Indole derivatives useful for treatment of CNS disorders
09/03/2008CN100415729C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
09/03/2008CN100415720C Quinoline derivative and quinazoline derivative, and medicinal composition containing the same
09/03/2008CN100415718C CASPASE inhibitors and use thereof
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
09/02/2008CA2411412C Indole derivatives useful for the treatment of cns disorders
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
09/02/2008CA2248338C 2-amino-4-bicycloamino-1,3,5-triazines as herbicides and plant growth regulators
08/2008
08/28/2008WO2008101891A1 Novel 4-amino-quinoline derivatives useful as anti-malaria drugs
08/28/2008WO2008079683A3 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
08/28/2008WO2008059513A3 Compounds suitable as modulators of hdl
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207689 Formamide Derivatives For The Treatment of Diseases
08/28/2008US20080207687 Quinoline Derivatives as Antibacterial Agents
08/28/2008US20080207686 Antibiotics
08/28/2008US20080207617 Prevent autophosphorylation of tyrosine kinase; therapy for hematopoietic cancer; leukemia; myelodysplastic syndrome
08/28/2008US20080207612 Analgesics; pain management
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080207588 Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines
08/28/2008US20080207528 Administering derivatives of 4-(3-pyrrolidinyloxy)quinoline
08/28/2008US20080206312 Therapeutic Morpholino-Substituted Compounds
08/28/2008US20080202578 Photocharge Separation Using Supramolecular Complex of Ii-Electron Type Extended Viologen Derivative And Porphyrin
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 277